| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/28/2001 | CA2392121A1 Tryptase inhibitors |
| 06/28/2001 | CA2391594A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
| 06/28/2001 | CA2389479A1 Butyne diol derivatives |
| 06/28/2001 | CA2384326A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs |
| 06/27/2001 | EP1110958A1 Alpha-arylethylpiperazine derivatives as neurokinin antagonists |
| 06/27/2001 | EP1110957A1 Benzazole derivatives and their use as JNK modulators |
| 06/27/2001 | EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 06/27/2001 | EP1110549A1 Use of trimebutine for treating pain |
| 06/27/2001 | EP1109924A2 Methylation of plasmid vectors |
| 06/27/2001 | EP1109918A2 Polypeptides, polynucleotides and uses thereof |
| 06/27/2001 | EP1109905A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 06/27/2001 | EP1109904A1 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof |
| 06/27/2001 | EP1109903A2 Human rna-associated proteins |
| 06/27/2001 | EP1109901A2 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109799A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors |
| 06/27/2001 | EP1109790A1 1, 2, 4-triazole-3-thione compounds |
| 06/27/2001 | EP1109789A1 Triptolide prodrugs having high aqueous solubility |
| 06/27/2001 | EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109570A2 Method of modulating memory effector t-cells and compositions |
| 06/27/2001 | EP1109556A2 New pharmaceutical uses for nos inhibitors |
| 06/27/2001 | EP1109555A1 Novel angiogenesis inhibitors |
| 06/27/2001 | EP1109554A2 Pipecolic acid derivatives for vision and memory disorders |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/27/2001 | EP1109536A1 New solid dose form of nanoparticulate naproxen |
| 06/27/2001 | EP1109534A1 Quick release pharmaceutical compositions of drug substances |
| 06/27/2001 | EP1109529A1 Lipid extract of the skeletonema algae |
| 06/27/2001 | EP0792167B1 Monofunctional and/or polyfunctional polylysine conjugates |
| 06/27/2001 | EP0701554B1 Novel compounds having a benzisoselen-azoline and -azine structure, method for preparing same and therapeutic uses thereof |
| 06/27/2001 | EP0690720B1 Therapeutic uses of bactericidal/permeability increasing protein products |
| 06/27/2001 | EP0676962B1 Enhanced pharmaceutical compositions for skin penetration for piroxicam |
| 06/27/2001 | CN1301298A Methods for prevention and treatment of cancer |
| 06/27/2001 | CN1301271A Methods for identifying inducers and inhibitors of propteolytic antibodies, compositions and their uses |
| 06/27/2001 | CN1301269A Template associated NPY Y2-receptor agonists |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1301154A Amide derivatives and nociceptin antagonists |
| 06/27/2001 | CN1301147A Pharmaceutical compositions capable of being gelled |
| 06/27/2001 | CN1301133A Food products having enhanced cocoa polyphenol content and processes for producing same |
| 06/27/2001 | CN1301131A Dipeptide apoptosis inhibitors and the use thereof |
| 06/27/2001 | CN1300618A Chinese medicine 'Qutongshujin Pill' |
| 06/27/2001 | CN1300610A Medical capsule for treating rheumatism |
| 06/27/2001 | CN1067683C Substituted morpholine derivatives and their use as therapeutic agents |
| 06/27/2001 | CN1067556C Pills for stimulating |
| 06/26/2001 | US6252116 Intermediates useful in a process for synthesizing COX-2 inhibitors |
| 06/26/2001 | US6252044 Riboflavin synthase polypeptide; for the controlled biosynthesis of riboflavin; for screening bactericides; for prevention of infection |
| 06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
| 06/26/2001 | US6251945 Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251929 Administering to a patient a hydantoin derivatives and salts as therapeutic and preventive agents for intractable vasculitis such as malignant rheumatoid arthritis(mra), periarteritis nodosa, wegener's granulomatosis etc. |
| 06/26/2001 | US6251926 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity |
| 06/26/2001 | US6251925 An agonists for human beta-3 adrenoceptor |
| 06/26/2001 | US6251923 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 06/26/2001 | US6251914 Treating cytokine mediated diseases |
| 06/26/2001 | US6251913 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
| 06/26/2001 | US6251434 Preparations of non-steroidal analgesics |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251426 Ibuprofen-containing softgels |
| 06/26/2001 | US6251392 Polypeptides for cell targets |
| 06/26/2001 | US6251371 Treatment of skin or mucosa inflammation by topical treatment with preparation containing dichlorobenzyl alcohol |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/21/2001 | WO2001044489A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | WO2001044474A1 2871 receptor, a g-protein coupled receptor and methods of use thereof |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044448A2 Human oxidoreductase proteins |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044294A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044260A2 Novel purines |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044248A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044217A1 Aminothiazole inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044207A2 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044170A1 Adamantane derivatives |
| 06/21/2001 | WO2001043775A2 Hydroxide-releasing agents as skin permeation enhancers |
| 06/21/2001 | WO2001043774A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 06/21/2001 | WO2001043773A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 06/21/2001 | WO2001043759A2 Use of 11cby popypeptides and polynuceotides |
| 06/21/2001 | WO2001043742A1 Novel processes for making- and a new crystalline form of- leflunomide |
| 06/21/2001 | WO2001043726A1 System and method for extended delivery of a therapeutic agent with its receptor loading dose |
| 06/21/2001 | WO2001043720A1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 06/21/2001 | WO2001043692A2 SALTS OF Cis-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANE-1-CARBOXYLIC ACID |
| 06/21/2001 | WO2001043691A2 Fragments and antagonists of heat shock protein 60 |
| 06/21/2001 | WO2001016136A3 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 06/21/2001 | WO2001010411A3 Implantable active ingredient depot |
| 06/21/2001 | WO2000071103A3 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |